Cosmetic composition comprising an antagonist of the neuropeptide Y receptor
The bacterial strain Bacillus licheniformis SEBR 2464 (A) (deposited at the Pasteur Institute under the number CNCM 1778) and its productive mutants are new. Independent claims are included for: (i) the preparation of an alpha 2-antagonist product (I), by culturing (A) (or its mutant) in a fermentat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slv |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SABADIE MICHEL SERRADEIL-LE GAL CLAUDINE VILAIN POL BONO FRANCOISE PEREILLO JEAN-MARIE BLANC-FERRAS ELISABETH MOUNIER REMY COURREGELONGUE JEAN PAUL RAYMOND BREDA BERNARD DUCASSE CATHERINE |
| description | The bacterial strain Bacillus licheniformis SEBR 2464 (A) (deposited at the Pasteur Institute under the number CNCM 1778) and its productive mutants are new. Independent claims are included for: (i) the preparation of an alpha 2-antagonist product (I), by culturing (A) (or its mutant) in a fermentation medium under conventional conditions until the broth has alpha 2-antagonist activity, then extracting the supernatant and concentrating to give a solid extract; (ii) (I) obtained as in (i), where the dry extract is utilized after dilution with a cosmetically acceptable solvent; and (iii) a cosmetic composition containing (I) obtained as above, together with a cosmetic excipient. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI1093803TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI1093803TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI1093803TT13</originalsourceid><addsrcrecordid>eNqNikEKwkAMAPfiQdQ_xAcILXvRc1EUvLkXT2VZ0xqwSdjE_1vEBwgDM4dZhmsnNqFTgSKTipGT8LcrGfEImWc8j8JkDjKAPxEY31UU1emBcIeKZW6p67AY8stw8_MqbE_H1J13qNKjaS7I6P3t0jaHuG9iSm385_kA-wA23Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cosmetic composition comprising an antagonist of the neuropeptide Y receptor</title><source>esp@cenet</source><creator>SABADIE MICHEL ; SERRADEIL-LE GAL CLAUDINE ; VILAIN POL ; BONO FRANCOISE ; PEREILLO JEAN-MARIE ; BLANC-FERRAS ELISABETH ; MOUNIER REMY ; COURREGELONGUE JEAN ; PAUL RAYMOND ; BREDA BERNARD ; DUCASSE CATHERINE</creator><creatorcontrib>SABADIE MICHEL ; SERRADEIL-LE GAL CLAUDINE ; VILAIN POL ; BONO FRANCOISE ; PEREILLO JEAN-MARIE ; BLANC-FERRAS ELISABETH ; MOUNIER REMY ; COURREGELONGUE JEAN ; PAUL RAYMOND ; BREDA BERNARD ; DUCASSE CATHERINE</creatorcontrib><description>The bacterial strain Bacillus licheniformis SEBR 2464 (A) (deposited at the Pasteur Institute under the number CNCM 1778) and its productive mutants are new. Independent claims are included for: (i) the preparation of an alpha 2-antagonist product (I), by culturing (A) (or its mutant) in a fermentation medium under conventional conditions until the broth has alpha 2-antagonist activity, then extracting the supernatant and concentrating to give a solid extract; (ii) (I) obtained as in (i), where the dry extract is utilized after dilution with a cosmetically acceptable solvent; and (iii) a cosmetic composition containing (I) obtained as above, together with a cosmetic excipient.</description><language>eng ; slv</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090228&DB=EPODOC&CC=SI&NR=1093803T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090228&DB=EPODOC&CC=SI&NR=1093803T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SABADIE MICHEL</creatorcontrib><creatorcontrib>SERRADEIL-LE GAL CLAUDINE</creatorcontrib><creatorcontrib>VILAIN POL</creatorcontrib><creatorcontrib>BONO FRANCOISE</creatorcontrib><creatorcontrib>PEREILLO JEAN-MARIE</creatorcontrib><creatorcontrib>BLANC-FERRAS ELISABETH</creatorcontrib><creatorcontrib>MOUNIER REMY</creatorcontrib><creatorcontrib>COURREGELONGUE JEAN</creatorcontrib><creatorcontrib>PAUL RAYMOND</creatorcontrib><creatorcontrib>BREDA BERNARD</creatorcontrib><creatorcontrib>DUCASSE CATHERINE</creatorcontrib><title>Cosmetic composition comprising an antagonist of the neuropeptide Y receptor</title><description>The bacterial strain Bacillus licheniformis SEBR 2464 (A) (deposited at the Pasteur Institute under the number CNCM 1778) and its productive mutants are new. Independent claims are included for: (i) the preparation of an alpha 2-antagonist product (I), by culturing (A) (or its mutant) in a fermentation medium under conventional conditions until the broth has alpha 2-antagonist activity, then extracting the supernatant and concentrating to give a solid extract; (ii) (I) obtained as in (i), where the dry extract is utilized after dilution with a cosmetically acceptable solvent; and (iii) a cosmetic composition containing (I) obtained as above, together with a cosmetic excipient.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwkAMAPfiQdQ_xAcILXvRc1EUvLkXT2VZ0xqwSdjE_1vEBwgDM4dZhmsnNqFTgSKTipGT8LcrGfEImWc8j8JkDjKAPxEY31UU1emBcIeKZW6p67AY8stw8_MqbE_H1J13qNKjaS7I6P3t0jaHuG9iSm385_kA-wA23Q</recordid><startdate>20090228</startdate><enddate>20090228</enddate><creator>SABADIE MICHEL</creator><creator>SERRADEIL-LE GAL CLAUDINE</creator><creator>VILAIN POL</creator><creator>BONO FRANCOISE</creator><creator>PEREILLO JEAN-MARIE</creator><creator>BLANC-FERRAS ELISABETH</creator><creator>MOUNIER REMY</creator><creator>COURREGELONGUE JEAN</creator><creator>PAUL RAYMOND</creator><creator>BREDA BERNARD</creator><creator>DUCASSE CATHERINE</creator><scope>EVB</scope></search><sort><creationdate>20090228</creationdate><title>Cosmetic composition comprising an antagonist of the neuropeptide Y receptor</title><author>SABADIE MICHEL ; SERRADEIL-LE GAL CLAUDINE ; VILAIN POL ; BONO FRANCOISE ; PEREILLO JEAN-MARIE ; BLANC-FERRAS ELISABETH ; MOUNIER REMY ; COURREGELONGUE JEAN ; PAUL RAYMOND ; BREDA BERNARD ; DUCASSE CATHERINE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI1093803TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2009</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SABADIE MICHEL</creatorcontrib><creatorcontrib>SERRADEIL-LE GAL CLAUDINE</creatorcontrib><creatorcontrib>VILAIN POL</creatorcontrib><creatorcontrib>BONO FRANCOISE</creatorcontrib><creatorcontrib>PEREILLO JEAN-MARIE</creatorcontrib><creatorcontrib>BLANC-FERRAS ELISABETH</creatorcontrib><creatorcontrib>MOUNIER REMY</creatorcontrib><creatorcontrib>COURREGELONGUE JEAN</creatorcontrib><creatorcontrib>PAUL RAYMOND</creatorcontrib><creatorcontrib>BREDA BERNARD</creatorcontrib><creatorcontrib>DUCASSE CATHERINE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SABADIE MICHEL</au><au>SERRADEIL-LE GAL CLAUDINE</au><au>VILAIN POL</au><au>BONO FRANCOISE</au><au>PEREILLO JEAN-MARIE</au><au>BLANC-FERRAS ELISABETH</au><au>MOUNIER REMY</au><au>COURREGELONGUE JEAN</au><au>PAUL RAYMOND</au><au>BREDA BERNARD</au><au>DUCASSE CATHERINE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cosmetic composition comprising an antagonist of the neuropeptide Y receptor</title><date>2009-02-28</date><risdate>2009</risdate><abstract>The bacterial strain Bacillus licheniformis SEBR 2464 (A) (deposited at the Pasteur Institute under the number CNCM 1778) and its productive mutants are new. Independent claims are included for: (i) the preparation of an alpha 2-antagonist product (I), by culturing (A) (or its mutant) in a fermentation medium under conventional conditions until the broth has alpha 2-antagonist activity, then extracting the supernatant and concentrating to give a solid extract; (ii) (I) obtained as in (i), where the dry extract is utilized after dilution with a cosmetically acceptable solvent; and (iii) a cosmetic composition containing (I) obtained as above, together with a cosmetic excipient.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; slv |
| recordid | cdi_epo_espacenet_SI1093803TT1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS SPIRITS VINEGAR WINE |
| title | Cosmetic composition comprising an antagonist of the neuropeptide Y receptor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A22%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SABADIE%20MICHEL&rft.date=2009-02-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI1093803TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |